Because the etiology of mucositis is multifactorial, approaches to prevention and
management have also been multifactorial. Effective prevention and management of …

Oral mucositis remains one of the most common and troubling side effects of standard
chemoradiation regimens used for the treatment of head and neck cancer. Virtually all …

The oral and gastrointestinal mucosa is frequently damaged during chemotherapy and
radiotherapy in patients with cancer, leading to a high incidence of mucositis (ie, oral …

Oral mucositis is one of the dose-limiting toxicities of several chemotherapy (CTX) agents.
There are suggested risk factors that could influence the development of mucositis. The …

Oral mucositis induced by conventional cytotoxic cancer therapies is a common and
significant clinical problem in oncology. Mucositis symptoms, which include severe pain …

Oral mucositis can be a significant problem for cancer patients and is frequently seen in the
patient population receiving high-dose head and neck radiation therapy (85%-100%), stem …

The incidence and the severity of chemotherapy-associated oral mucositis were determined
in a retrospective analysis of 150 patients with various solid tumors. In addition, possible risk …

Oral mucositis is a common complication in cancer patients receiving chemotherapy and/or
radiation therapy. Nearly all patients undergoing myeloablative therapy for stem-cell or bone …

Introduction: Oral mucositis is a frequent and devastating toxicity secondary to cancer
treatment, which may affect 20–40% of patients receiving conventional chemotherapy and …

Mucosal damage is one of the most common adverse effects of radiotherapy and of cytotoxic
therapy for cancer. With prevalence between 10% and 100%, depending of the cytotoxic …